Inflammatory bowel disease (IBD) after solid organ transplantation is rare. We report new-onset Crohn’s disease successfully treated with anti-tnfα therapy in a cardiac transplantation recipient. Our case highlights the importance… Click to show full abstract
Inflammatory bowel disease (IBD) after solid organ transplantation is rare. We report new-onset Crohn’s disease successfully treated with anti-tnfα therapy in a cardiac transplantation recipient. Our case highlights the importance of including IBD in the differential of chronic diarrhea despite significant immunosuppression and suggests that anti-tnf alpha therapy is effective in post-transplant IBD.
               
Click one of the above tabs to view related content.